|
Recurrent Intraocular Melanoma
Current Clinical Trials
The prognosis for any patient with recurring or relapsing disease is poor,
regardless of cell type or stage. The question and selection of further
treatment depends on many factors, including the extent of the lesion, age and
health of the patient, prior treatment, and site of recurrence, as well as
individual patient considerations. Clinical trials are appropriate and should
be considered whenever possible.
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent intraocular melanoma. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
Back to Top
< Previous Section | Next Section > |
